Javascript must be enabled to continue!
EFFECT OF APOMORPHINE ON ADRENAL MEDULLARY CATECHOLAMINE LEVELS
View through CrossRef
Summary—The effects of the dopamine receptor agonist, apomorphine, on the total catecholamine content of the adrenal medulla were studied in normotensive rats. Apomorphine (3, 15, 30 mg/kg SC) induced a dose‐dependent decrease in catecholamine content of the adrenal gland. The action of apomorphine was suppressed by previous treatment with the non specific dopamine receptor antagonist, haloperidol (9 mg/kg 1P), or the D2 antagonist domperidone (2 mg/kg 1P), but not by the D1 antagonist SCH 23390 (1 mg/kg 1P). The apomorphine‐induced decrease in adrenal catecholamine concentration was suppressed by denervation of the adrenal medulla,i.e.unilateral section of splanchnic fibers performed 5 days before. These results show that, under our experimental conditions, the effect of apomorphine is due to the activation of D2 dopamine receptors probably located on splanchnic nerve endings and suggest the existence of a peripheral D2 dopaminergic system which modulates adrenal medullary catecholamine content.
Title: EFFECT OF APOMORPHINE ON ADRENAL MEDULLARY CATECHOLAMINE LEVELS
Description:
Summary—The effects of the dopamine receptor agonist, apomorphine, on the total catecholamine content of the adrenal medulla were studied in normotensive rats.
Apomorphine (3, 15, 30 mg/kg SC) induced a dose‐dependent decrease in catecholamine content of the adrenal gland.
The action of apomorphine was suppressed by previous treatment with the non specific dopamine receptor antagonist, haloperidol (9 mg/kg 1P), or the D2 antagonist domperidone (2 mg/kg 1P), but not by the D1 antagonist SCH 23390 (1 mg/kg 1P).
The apomorphine‐induced decrease in adrenal catecholamine concentration was suppressed by denervation of the adrenal medulla,i.
e.
unilateral section of splanchnic fibers performed 5 days before.
These results show that, under our experimental conditions, the effect of apomorphine is due to the activation of D2 dopamine receptors probably located on splanchnic nerve endings and suggest the existence of a peripheral D2 dopaminergic system which modulates adrenal medullary catecholamine content.
Related Results
A study of tolerance to apomorphine
A study of tolerance to apomorphine
The present study was designed to investigate tolerance to several pharmacological effects of apomorphine.Changes in blood pressure, heart rate, plasma noradrenaline levels, rectal...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Pediatric Adrenal Hydatid Cyst: A Case Report and Literature Review
Pediatric Adrenal Hydatid Cyst: A Case Report and Literature Review
Abstract
Introduction: Echinococcosis is a zoonotic disease that can affect various organs and tissues in the human body. However, primary adrenal hydatid cyst (AHC) is rare and ma...
MON-510 Unmasking A Lymphoma: A Case Of Primary Adrenal Lymphoma Presenting As Adrenal Insufficiency
MON-510 Unmasking A Lymphoma: A Case Of Primary Adrenal Lymphoma Presenting As Adrenal Insufficiency
Abstract
Disclosure: S. Ei: None. S.S. Karnik: None. S.S. Kowsika: None.
Introduction: Primary adrenal lymphoma, although very rare, is increasi...
Bilateral Adrenal Incidentalomas, Uncommon Presentation and Very Rare Pathology
Bilateral Adrenal Incidentalomas, Uncommon Presentation and Very Rare Pathology
Abstract
Background: Adrenal incidentaloma is an adrenal mass larger than 1cm accidentally discovered by radiological examination. The incidentalomas should be evalu...
Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (≤1 cm): the Ruijin clinical experience in 88 patients
Retroperitoneoscopic partial adrenalectomy for small adrenal tumours (≤1 cm): the Ruijin clinical experience in 88 patients
Study Type – Therapy (case series)
Level of Evidence 4
OBJECTIVE
To present our experience of retroper...
Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study
Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study
AbstractWe investigated whether administration of the catechol‐O‐methyl transferase (COMT) inhibitor entacapone, at doses of 200 mg and 400 mg, alters the pharmacokinetics of apomo...
Adrenergic receptors of adrenal medullary vasculature
Adrenergic receptors of adrenal medullary vasculature
The present study evaluates possible effects of adrenal catecholamines, released by splanchnic nerve stimulation, on adrenal medullary blood flow (MQ) and adrenal catecholamine sec...

